Administration of CIGB500 in healthy volunteers. Phase I study on scaling up dosages.
Phase of Trial: Phase I
Latest Information Update: 07 Mar 2017
At a glance
- Drugs CIGB 500 (Primary)
- Indications Myocardial infarction
- Focus Adverse reactions
- 31 Jul 2013 Status changed from active, no longer recruiting to completed as reported by Cuban Clinical Trial Registry.
- 30 Aug 2011 New trial record